Literature DB >> 27050129

UHM-ULM interactions in the RBM39-U2AF65 splicing-factor complex.

Galina A Stepanyuk1, Pedro Serrano1, Eigen Peralta2, Carol L Farr1, Herbert L Axelrod3, Michael Geralt1, Debanu Das3, Hsiu-Ju Chiu3, Lukasz Jaroszewski3, Ashley M Deacon3, Scott A Lesley1, Marc-André Elsliger1, Adam Godzik3, Ian A Wilson1, Kurt Wüthrich1, Daniel R Salomon2, James R Williamson1.   

Abstract

RNA-binding protein 39 (RBM39) is a splicing factor and a transcriptional co-activator of estrogen receptors and Jun/AP-1, and its function has been associated with malignant progression in a number of cancers. The C-terminal RRM domain of RBM39 belongs to the U2AF homology motif family (UHM), which mediate protein-protein interactions through a short tryptophan-containing peptide known as the UHM-ligand motif (ULM). Here, crystal and solution NMR structures of the RBM39-UHM domain, and the crystal structure of its complex with U2AF65-ULM, are reported. The RBM39-U2AF65 interaction was confirmed by co-immunoprecipitation from human cell extracts, by isothermal titration calorimetry and by NMR chemical shift perturbation experiments with the purified proteins. When compared with related complexes, such as U2AF35-U2AF65 and RBM39-SF3b155, the RBM39-UHM-U2AF65-ULM complex reveals both common and discriminating recognition elements in the UHM-ULM binding interface, providing a rationale for the known specificity of UHM-ULM interactions. This study therefore establishes a structural basis for specific UHM-ULM interactions by splicing factors such as U2AF35, U2AF65, RBM39 and SF3b155, and a platform for continued studies of intermolecular interactions governing disease-related alternative splicing in eukaryotic cells.

Entities:  

Keywords:  CAPERα; HCC1; RBM39; RNA-binding protein 39; RNA-binding proteins; U2AF homology motif; U2AF5; UHM; ULM; alternative splicing

Mesh:

Substances:

Year:  2016        PMID: 27050129      PMCID: PMC4822562          DOI: 10.1107/S2059798316001248

Source DB:  PubMed          Journal:  Acta Crystallogr D Struct Biol        ISSN: 2059-7983            Impact factor:   7.652


  74 in total

1.  PUF60: a novel U2AF65-related splicing activity.

Authors:  P S Page-McCaw; K Amonlirdviman; P A Sharp
Journal:  RNA       Date:  1999-12       Impact factor: 4.942

2.  Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA.

Authors:  Torsten Herrmann; Peter Güntert; Kurt Wüthrich
Journal:  J Mol Biol       Date:  2002-05-24       Impact factor: 5.469

3.  Substructure solution with SHELXD.

Authors:  Thomas R Schneider; George M Sheldrick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-09-28

4.  CAPER-α alternative splicing regulates the expression of vascular endothelial growth factor₁₆₅ in Ewing sarcoma cells.

Authors:  Gangxiong Huang; Zhichao Zhou; Hua Wang; Eugenie S Kleinerman
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

5.  Evidence for substrate-specific requirement of the splicing factor U2AF(35) and for its function after polypyrimidine tract recognition by U2AF(65).

Authors:  S Guth; C Martínez; R K Gaur; J Valcárcel
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

6.  Transient interaction of BBP/ScSF1 and Mud2 with the splicing machinery affects the kinetics of spliceosome assembly.

Authors:  B Rutz; B Séraphin
Journal:  RNA       Date:  1999-06       Impact factor: 4.942

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  1H, 13C and 15N chemical shift referencing in biomolecular NMR.

Authors:  D S Wishart; C G Bigam; J Yao; F Abildgaard; H J Dyson; E Oldfield; J L Markley; B D Sykes
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

9.  Overexpression of HCC1/CAPERα may play a role in lung cancer carcinogenesis.

Authors:  Yurong Chai; Xinxin Liu; Liping Dai; Yang Li; Mei Liu; Jian-Ying Zhang
Journal:  Tumour Biol       Date:  2014-03-19

10.  Spatial mapping of splicing factor complexes involved in exon and intron definition.

Authors:  Jonathan D Ellis; David Llères; Marco Denegri; Angus I Lamond; Javier F Cáceres
Journal:  J Cell Biol       Date:  2008-06-16       Impact factor: 10.539

View more
  21 in total

Review 1.  Altered RNA Processing in Cancer Pathogenesis and Therapy.

Authors:  Esther A Obeng; Connor Stewart; Omar Abdel-Wahab
Journal:  Cancer Discov       Date:  2019-10-14       Impact factor: 39.397

2.  U2AF65 assemblies drive sequence-specific splice site recognition.

Authors:  Manel Tari; Valérie Manceau; Jean de Matha Salone; Asaki Kobayashi; David Pastré; Alexandre Maucuer
Journal:  EMBO Rep       Date:  2019-07-04       Impact factor: 8.807

3.  Protein 4.1R Exon 16 3' Splice Site Activation Requires Coordination among TIA1, Pcbp1, and RBM39 during Terminal Erythropoiesis.

Authors:  Shu-Ching Huang; Henry S Zhang; Brian Yu; Ellen McMahon; Dan T Nguyen; Faye H Yu; Alexander C Ou; Jennie Park Ou; Edward J Benz
Journal:  Mol Cell Biol       Date:  2017-04-14       Impact factor: 4.272

4.  Tracing and Characterizing the Development of Transplanted Female Germline Stem Cells In Vivo.

Authors:  Changqing Wu; Bo Xu; Xiaoyong Li; Wenzhi Ma; Ping Zhang; Xuejin Chen; Ji Wu
Journal:  Mol Ther       Date:  2017-05-18       Impact factor: 11.454

5.  The RNA-binding protein caper is required for sensory neuron development in Drosophila melanogaster.

Authors:  Eugenia C Olesnicky; Jeremy M Bono; Laura Bell; Logan T Schachtner; Meghan C Lybecker
Journal:  Dev Dyn       Date:  2017-06-29       Impact factor: 3.780

6.  An Unusual U2AF2 Inhibits Splicing and Attenuates the Virulence of the Human Protozoan Parasite Entamoeba histolytica.

Authors:  Gretter González-Blanco; Guillermina García-Rivera; Patricia Talmás-Rohana; Ester Orozco; José Manuel Galindo-Rosales; Cristina Vélez; Odila Salucedo-Cárdenas; Elisa Azuara-Liceaga; Mario Alberto Rodríguez-Rodríguez; Tomoyoshi Nozaki; Jesús Valdés
Journal:  Front Cell Infect Microbiol       Date:  2022-06-17       Impact factor: 6.073

7.  Aberrant RNA Splicing in Cancer.

Authors:  Luisa Escobar-Hoyos; Katherine Knorr; Omar Abdel-Wahab
Journal:  Annu Rev Cancer Biol       Date:  2018-11-28

Review 8.  Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities.

Authors:  Maxime Blijlevens; Jing Li; Victor W van Beusechem
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

Review 9.  RNA Regulators in Leukemia and Lymphoma.

Authors:  Camila Prieto; Michael G Kharas
Journal:  Cold Spring Harb Perspect Med       Date:  2020-05-01       Impact factor: 6.915

10.  Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia.

Authors:  Eric Wang; Sydney X Lu; Alessandro Pastore; Xufeng Chen; Jochen Imig; Stanley Chun-Wei Lee; Kathryn Hockemeyer; Yohana E Ghebrechristos; Akihide Yoshimi; Daichi Inoue; Michelle Ki; Hana Cho; Lillian Bitner; Andreas Kloetgen; Kuan-Ting Lin; Taisuke Uehara; Takashi Owa; Raoul Tibes; Adrian R Krainer; Omar Abdel-Wahab; Iannis Aifantis
Journal:  Cancer Cell       Date:  2019-02-21       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.